CMMB
Chemomab Therapeutics Ltd.
stockNASDAQADR

Market OpenNov 2, 2026 11:40:49 AM EST

1.20USD+1.695%(+0.02)33,926

1.0300Bid1.6100Ask0.5800Spread

CMMB Financials

In Q2 FY 2026 (ended June 30, 2026), Chemomab Therapeutics Ltd. (CMMB) reported net income of −$2.17M and assets of $10.24M.